Sort:
Open Access Issue
Establishment and Evaluation of a BALB/c Mouse Model of Celiac Disease Caused by Dietary Gluten
Food Science 2022, 43(21): 117-125
Published: 15 November 2022
Abstract PDF (4.5 MB) Collect
Downloads:12
Objective

A mouse model of celiac disease induced by gluten was established and its feasibility was evaluated by testing diagnostic indicators of celiac disease.

Methods

Female BALB/c mice aged 6–8 weeks fed a gluten-free diet for more than three generations were randomly divided into two groups, control and celiac disease (CeD). On the first day of the experiment, the mice in the CeD group were fed a gluten-containing diet (2.5 g/kg) instead of the gluten-free diet for 30 days while those in the control group were still fed the gluten-free diet. In the first three weeks, each mouse in the CeD group was intraperitoneally injected with 0.2 mL of 0.01 mol/L phosphate buffered saline containing 150 μg of gliadin twice a week. In the fourth week, the rear footpad of each mouse in this group was injected twice with 50 μg of gliadin emulsified in 50 μL of Freund’s complete adjuvant (on the first and fourth days respectively). Fluorescein isothiocyanate-labeled dextran levels were used to indicate intestinal permeability in mice; real-time quantitative polymerase chain reaction (qPCR) was used to detect the expression of tight junction proteins (ZO-1, ZO-2 and claudin-1), inflammatory cytokines (interleukin (IL)-15, IFN-γ and IL-4) and immune cell marker genes (CD4, CD19 and CD138) in the duodenum; and the enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of total transglutaminase (tTG) and zonulin in duodenal tissue.

Results

The intestinal barrier of the mice in the CeD group was damaged, the length of small intestinal villi was significantly decreased, the mRNA expression of the gene encoding transglutaminase 2 (TG2) was significantly increased (P < 0.05), and the relative expression levels of genes encoding cytokines and immune cell markers associated with celiac disease were notably increased compared with the control group.

Conclusion

The animal model can effectively mimic the key clinical features of celiac disease as evidenced by intestinal pathology, intestinal barrier, and immune response. It may be used in future research to develop potential therapeutics for celiac disease.

Open Access Issue
Mouse β-Defensin 14-Expressing Lactiplantibacillus plantarum Attenuates Acute Colitis in Mice
Food Science 2022, 43(17): 1-11
Published: 15 September 2022
Abstract PDF (4.5 MB) Collect
Downloads:5

The antimicrobial peptide β-defensin also has an immunomodulatory effect. It plays an important role in maintaining intestinal homeostasis. This study aimed to investigate the role of mouse β-defensin 14 (mBD14) in inflammatory bowel disease (IBD). Lactiplantibacillus plantarum was used as a carrier for targeted delivery of mBD14 into the mouse intestine by genetic engineering technology. Meanwhile, the effect of the bacterium on acute colitis induced by dextran sulfate sodium (DSS) in mice was assessed. The results showed that mBD14-expressing Lactiplantibacillus plantarum alleviated the symptoms of colitis. Moreover, the bacterium modulated the gut microbiota, protected intestinal barrier function, attenuated the expression of pro-inflammatory cytokines and inhibited the activation of NOD-like receptor pyrin domain containing 3 (NLRP3) and downstream inflammatory pathways. Thus, the current study reveals a protective effect of mBD14-expressing Lactiplantibacillus plantarum against DSS-induced colitis, which provides a rationale for the development of prophylactic strategies based on probiotics and antimicrobial peptides for the prevention of IBD.

Open Access Issue
Diallyl Trisulfide Relieves Food Allergy Caused by Ovalbumin by Regulating the Intestinal Barrier
Food Science 2022, 43(9): 128-135
Published: 15 May 2022
Abstract PDF (3.3 MB) Collect
Downloads:3
Objective

This study investigated the effect and mechanism of oral administration of diallyl trisulfide (DATS) on ovalbumin (OVA)- and Al(OH)3-induced food allergy in mice.

Methods

Female Balb/c mice (about 5 weeks old) were randomly divided into three groups: control, food allergy (FA) and FA + DATS. The experimental groups were injected intraperitoneally with 0.2 mL sterile physiological saline containing 50 μg of OVA and 1 mg of Al(OH)3 on day 0 and day 14, and 50 mg of OVA (dissolved in 250 μL of sterile physiological saline) was intragastrically administered at one-day intervals for six consecutive times starting from the 28th day. Fluorescein-labeled dextran (fluorescein isothiocyanate-dextran) was used to detect the permeability of the small intestine in mice; reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression levels of Th2 type (T helper 2) cytokine interleukin-4 (IL-4), IL-5 and IL-13 in mouse jejunum tissue; enzyme-linked immunosorbent assay (ELISA) was used to measure serum OVA-specific immunoglobulin E (OVA-sIgE) and mast cell protease 1 (mMCP-1) levels.

Results

The FA + DATS group had a significantly lower incidence of diarrhea and a smaller decrease in body temperature than the FA group. Moreover, serum OVA-sIgE and mMCP-1 levels and Th2 type cytokine levels in jejunum were significantly reduced (P < 0.01 or 0.001), and food allergy symptoms and intestinal barrier were alleviated.

Conclusion

Supplementation of DATS can enhance intestinal barrier function and effectively reduce the immune response of food allergy, thereby alleviating the symptoms of food allergy.

Open Access Issue
Selection of Lactobacillus with High Bile Salt Hydrolase Activity and Its Preventive and Therapeutic Effects against Neonatal Jaundice in Rats
Food Science 2024, 45(11): 118-127
Published: 15 June 2024
Abstract PDF (11.9 MB) Collect
Downloads:17

This study aimed to select Lactobacillus with high bile salt hydrolase (BSH) and to explore its protective role against neonatal jaundice. The LBS selective medium supplemented with 25 U/mL nystatin was used to screen and identify Lactobacillus strains isolated from the feces of healthy newborns and breast milk. L. rhamnosus (LGG) was used as a positive control to evaluate the in vitro probiotic properties and bile salt hydrolase activity of the Lactobacillus strains. Thereafter, the protective effect and mechanism of the selected isolates with high bile salt hydrolase activity against phenylhydrazine hydrochloride (PHZ)-induced neonatal jaundice in rats were investigated by analyzing serum bilirubin levels, hepatotoxicity, and the expression of inflammatory cytokines and nuclear transcription factors in the liver. The results showed that compared with the LGG, L. gasseri FWJL-5, which was isolated from infant feces, exhibited outstanding in vitro probiotic properties and higher bile salt hydrolase activity than LGG. L. gasseri FWJL-5 significantly alleviated the increase in serum bilirubin levels, liver tissue swelling and hemolysis in PHZ-treated neonatal rats, reduced the release of hepatic enzymes, inhibited the secretion of proinflammatory cytokines, and promoted the expression of UGT1A1, pregnane X receptor (PXR), and farnesol X receptor (FXR). Taken together, L. gasseri FWJL-5 could regulate bilirubin metabolism in the liver by up-regulating the expression of FXR/PXR and UGT1A1, thereby alleviating neonatal jaundice in rats. Our findings may provide new ideas for the prevention and treatment of neonatal jaundice by L. gasseri.

Total 4